WASHINGTON (MedPage Today) — The FDA has approved a new sublingual film formulation of the opioid dependence treatment combination buprenorphrine/naloxone (Suboxone). (Source: MedPage Today Public Health)
Opioid Dependence Drug Gets Okay for New Delivery Mode
Previous post: Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone Soluble-Films.
Next post: Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia
